Blog

DISCLAIMER: This Blog is a general communication of Keating and is not intended to be a solicitation to purchase or sell any security. The information contained in this Blog should not be considered to be part of Keating Capital's Prospectus. The offering and sale of Keating Capital's shares may only be made pursuant to Keating Capital’s Prospectus, which includes certain risk factors in the “Risk Factors” section of such Prospectus.

Keating Capital, Inc. (www.KeatingCapital.com), a pre-IPO investment fund, announced that on September 26, 2011, it made a $3 million common stock investment in TrueCar, Inc. (www.TrueCar.com) (“TrueCar”). Through this most recent closing, TrueCar has raised over $50 million in the common stock financing round.

 

Founded in 2005 and based in Santa Monica, California, TrueCar is an online research and pricing tool for consumers interested in buying a new or used vehicle whereby a consumer can research any make and model and see a histogram of actual transaction prices for that vehicle in a specific geographic area. Through TrueCar’s platform, consumers also have access to average prices paid, recent sales data, monthly price trends and vehicle pricing details, which show dealer cost, and factory invoice, as well as customer and dealer incentives being offered.

TrueCar is Keating Capital’s ninth new portfolio company investment in 2011. With this investment, Keating Capital has now invested a total of $31.4 million in 13 portfolio companies, including $27.8 million invested year-to-date.

About Keating Capital, Inc.

Keating Capital (www.KeatingCapital.com) is a business development company that specializes in making pre-IPO investments in innovative, high growth private companies that are committed to and capable of becoming public. Keating Capital provides individual investors with the ability to participate in a unique fund that invests in a private company’s late stage, pre-IPO financing round – an opportunity that has historically been reserved for institutional investors.

To be added to Keating Capital’s distribution list, go to www.KeatingCapital.com/contact.

FOR IMMEDIATE RELEASE
Contact:
Margie L. Blackwell
Investor Relations Director
Keating Capital, Inc.
mb@keatinginvestments.com
(720) 889-0133

Forward-Looking Statements

This press release may contain statements of a forward-looking nature relating to future events. These forward-looking statements are subject to the inherent uncertainties in predicting future results and conditions. These statements reflect Keating Capital’s current beliefs, and a number of important factors could cause actual results to differ materially from those expressed in this press release, including the factors set forth in “Risk Factors” set forth in Keating Capital’s Form 10-K and Form 10-Q filed with the Securities and Exchange Commission (“SEC”), and subsequent filings with the SEC. Please refer to Keating Capital’s SEC filings for a more detailed discussion of the risks and uncertainties associated with its business, including but not limited to the risks and uncertainties associated with investing in micro- and small-cap companies. Except as required by the federal securities laws, Keating Capital undertakes no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise. The reference to Keating Capital’s website has been provided as a convenience, and the information contained on such website is not incorporated by reference into this press release.

 

Keating Capital, Inc. announced that on August 25, 2011, it made a $4 million investment and led the $13 million Series D Convertible Preferred Stock round of Metabolon, Inc. (www.Metabolon.com) (“Metabolon”).  Other investors in the Series D round include existing investors Sevin Rosen Funds, Aurora Funds, Harris & Harris Group, Syngenta Ventures, Fletcher Spaght and Fulcrum Financial Partners.

Founded in 2000 and headquartered in Research Triangle Park, North Carolina, Metabolon is a molecular diagnostics and services company offering a novel metabolic profiling technology that uses advanced bioinformatics and data analytics software to identify, quantify, and analyze biochemical processes occurring within cells.  Metabolon’s end-to-end profiling service is used by leading academic institutions and pharmaceutical, biotechnology, agriculture, and consumer products companies to develop more efficacious drugs, diagnostic tests, and consumer and agricultural products.  Metabolon is utilizing biomarkers identified by its technology in the development of molecular diagnostic tests intended to detect and measure the aggression and stage of diseases such as diabetes and cancer.

Timothy J. Keating, Keating Capital’s CEO stated:  “We are pleased to diversify our portfolio with the addition of our first life sciences company.  We are delighted to be an equity partner with Metabolon, and we believe that the confluence of the company’s outstanding management team, world class scientific advisory board and blue chip client roster will ultimately lead to major disruptive innovations in the delivery of medicines to patients worldwide.”

Metabolon is Keating Capital’s sixth new portfolio company investment in 2011.  With this investment, Keating Capital has now invested a total of $23.0 million in 10 portfolio companies, of which $19.4 million has been invested in 2011.”

About Keating Capital, Inc.

Keating Capital (www.KeatingCapital.com) is a business development company that specializes in making pre-IPO investments in innovative, high growth private companies that are committed to and capable of becoming public.  Keating Capital provides individual investors with the ability to participate in a unique fund that invests in a private company’s late stage, pre-IPO financing round — an opportunity that has historically been reserved for institutional investors.

To be added to Keating Capital’s distribution list, go to www.KeatingCapital.com/contact.

FOR IMMEDIATE RELEASE

Contact:

Margie L. Blackwell

Investor Relations Director

Keating Capital, Inc.

mb@keatinginvestments.com

(720) 889-0133

 

Forward-Looking Statements

This press release may contain statements of a forward-looking nature relating to future events. These forward-looking statements are subject to the inherent uncertainties in predicting future results and conditions. These statements reflect Keating Capital’s current beliefs, and a number of important factors could cause actual results to differ materially from those expressed in this press release, including the factors set forth in “Risk Factors” set forth in Keating Capital’s Form 10-K and Form 10-Q filed with the Securities and Exchange Commission (“SEC”), and subsequent filings with the SEC.  Please refer to Keating Capital’s SEC filings for a more detailed discussion of the risks and uncertainties associated with its business, including but not limited to the risks and uncertainties associated with investing in micro- and small-cap companies.  Except as required by the federal securities laws, Keating Capital undertakes no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise.  The reference to Keating Capital’s Web site has been provided as a convenience, and the information contained on such Web site is not incorporated by reference into this press release.

 

 

July 12, 2011 – Greenwood Village, Colorado – Keating Capital, Inc. announced today that it concluded its public offering on June 30, 2011, raising aggregate gross proceeds of $86,800,000. The final closing of escrowed funds from subscribing investors occurred on July 11, 2011. A total of 8,713,659 shares of common stock were sold in the public offering at an average price of $9.96 per share, before dealer manager fees and commissions.

The public offering was a continuous public offering which was initially declared effective by the SEC on June 11, 2009, with the first closing held on January 11, 2010. Andrews Securities, LLC, a Denver-based broker-dealer, served as the managing dealer of the public offering, with a selling group of over 50 independent broker-dealers.

Prior to the public offering, Keating Capital had been seeded with $5,699,000 in a private placement of common stock. Following the public offering, Keating Capital now has a total of 9,283,559 shares of common stock issued and outstanding and over 3,900 individual shareholders. The fund’s capital structure consists entirely of common stock, with no options, warrants or other types of dilutive securities issued or outstanding. Moreover, Keating Capital does not use leverage or borrowed money to fund its portfolio company investments.

The next important milestone for Keating Capital is the planned listing of its common stock on the Nasdaq Capital Market under the reserved proposed ticker symbol KIPO. The Nasdaq listing is anticipated to occur by the end of 2011. No additional shares will be offered to the public as part of the listing process.

Timothy J. Keating, Keating Capital’s CEO stated: “The completion of our $86,800,000 public offering is a great success for the fund. To the best of our knowledge, Keating Capital is the only fund of its kind exclusively dedicated to pre-IPO investing in the United States. With our transparency as a publicly reporting fund and with the liquidity we intend to provide through our planned Nasdaq listing, Keating Capital is a unique access vehicle for individual investors to participate in the growth of later-stage private companies before they go public.”

About Keating Capital, Inc.

Keating Capital (www.KeatingCapital.com) is a business development company that specializes in making pre-IPO investments in innovative, high growth private companies that are committed to and capable of becoming public. Keating Capital provides individual investors with the ability to participate in a unique fund that invests in a private company’s late stage, pre-IPO financing round - an opportunity that has historically been reserved for institutional investors.

To be added to Keating Capital’s distribution list, go to www.KeatingCapital.com/contact.

Contact:
Margie L. Blackwell
Investor Relations Director
Keating Capital, Inc.
mb@keatinginvestments.com
(720) 889-0133

Forward-Looking Statements
This press release may contain statements of a forward-looking nature relating to future events. These forward-looking statements are subject to the inherent uncertainties in predicting future results and conditions. These statements reflect Keating Capital’s current beliefs, and a number of important factors could cause actual results to differ materially from those expressed in this press release, including the factors set forth in “Risk Factors” in Keating Capital’s annual report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on February 28, 2011, and subsequent filings with the SEC. Please refer to Keating Capital’s SEC filings for a more detailed discussion of the risks and uncertainties associated with its business, including but not limited to the risks and uncertainties associated with investing in micro- and small-cap companies. Except as required by the federal securities laws, Keating Capital undertakes no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise. The reference to Keating Capital’s Web site has been provided as a convenience, and the information contained on such Web site is not incorporated by reference into this press release.

 

Keating Capital, Inc. announced that it recently was the lead investor in an $8 million private purchase of common stock from certain founders and management employees of Corsair Components, Inc., a designer and supplier of high-performance components to the personal computer, or PC, gaming hardware market. Keating Capital acquired $4 million of common stock in the transaction, which was completed on July 6, 2011.

About Keating Capital, Inc.

Keating Capital (www.KeatingCapital.com) is a business development company that specializes in making pre-IPO investments in innovative, high growth private companies that are committed to and capable of becoming public. Keating Capital provides individual investors with the ability to participate in a unique fund that invests in a private company’s late stage, pre-IPO financing round – an opportunity that has historically been reserved for institutional investors.

To be added to Keating Capital’s distribution list, go to www.KeatingCapital.com/contact.

FOR IMMEDIATE RELEASE
Contact:
Margie L. Blackwell
Investor Relations Director
Keating Capital, Inc.
mb@keatinginvestments.com
(720) 889-0133

Forward-Looking Statements
This press release may contain statements of a forward-looking nature relating to future events. These forward-looking statements are subject to the inherent uncertainties in predicting future results and conditions. These statements reflect Keating Capital’s current beliefs, and a number of important factors could cause actual results to differ materially from those expressed in this press release, including the factors set forth in “Risk Factors” in Keating Capital’s annual report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on February 28, 2011, and subsequent filings with the SEC. Please refer to Keating Capital’s SEC filings for a more detailed discussion of the risks and uncertainties associated with its business, including but not limited to the risks and uncertainties associated with investing in micro- and small-cap companies. Except as required by the federal securities laws, Keating Capital undertakes no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise. The reference to Keating Capital’s Web site has been provided as a convenience, and the information contained on such Web site is not incorporated by reference into this press release.

 

Keating Capital announced that it recently invested $3 million in the Series F Preferred Stock round of Xtime, Inc. (“Xtime”).  Keating Capital was the lead investor in this round.

Founded in 1999 and headquartered in Redwood Shores, California, Xtime is a software as a service provider of Web scheduling and CRM solutions for automotive service departments.  Xtime has enrolled over 3,000 dealerships since the launch of its ServiceCRM™ platform, which automates and integrates all Xtime products into a unified solution for fixed operations (consisting of service, parts, and body shop).  Xtime products include online, Smartphone, dealership and call center scheduling, online bill pay, electronic inspections, electronic service menus, service marketing, greeter board, advanced shop control, management reporting and certified dealer management system integration.

Xtime is the exclusive or preferred provider for the following automobile original equipment manufacturers:  Lexus, Mercedes-Benz, Infiniti, Volkswagen, Toyota Canada, Hyundai, Chrysler, Nissan, Audi, BMW and Toyota U.S.  Many of the industry’s leading dealership groups also have contracts with Xtime, including:

  • AutoNation, Inc. (NYSE:  AN)
  • Group 1 Automotive (NYSE:  GPI)
  • Sonic Automotive (NYSE:  SAH)

Timothy J. Keating, Keating Capital’s CEO stated:  “We are pleased to lead Xtime’s Series F Preferred Stock round and to further diversify our portfolio.  Xtime is our fourth portfolio company investment in 2011, and the eighth since we launched the fund last year.  It is also the first time that we have acted as the lead investor, and Xtime is our first investment in the software space.  At $3 million, our Xtime investment is our largest to date and slightly above the $2.5 million of each of our three investments in the first quarter of 2011.”

 

About Keating Capital, Inc.

Keating Capital (www.KeatingCapital.com) is a business development company that specializes in making pre-IPO investments in innovative, high growth private companies that are committed to and capable of becoming public.  Keating Capital provides individual investors with the ability to participate in a unique fund that invests in a private company’s late stage, pre-IPO financing round — an opportunity that has historically been reserved for institutional investors.

To be added to Keating Capital’s distribution list, go to www.KeatingCapital.com/contact.

FOR IMMEDIATE RELEASE

Contact:

Margie L. Blackwell

Investor Relations Director

Keating Capital, Inc.

5251 DTC Parkway, Suite 1000

Greenwood Village, CO  80111

mb@keatinginvestments.com

(720) 889-0133

 

Forward-Looking Statements

This press release may contain statements of a forward-looking nature relating to future events. These forward-looking statements are subject to the inherent uncertainties in predicting future results and conditions. These statements reflect Keating Capital’s current beliefs, and a number of important factors could cause actual results to differ materially from those expressed in this press release, including the factors set forth in “Risk Factors” in Keating Capital’s annual report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on February 28, 2011, and subsequent filings with the SEC. Please refer to Keating Capital’s SEC filings for a more detailed discussion of the risks and uncertainties associated with its business, including but not limited to the risks and uncertainties associated with investing in micro- and small-cap companies. Except as required by the federal securities laws, Keating Capital undertakes no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise. The reference to Keating Capital’s Web site has been provided as a convenience, and the information contained on such Web site is not incorporated by reference into this press release.

 

 

Keating Capital, Inc. noted on May 27, 2011,  that one of its portfolio companies, Solazyme, Inc., completed an initial public offering of its common stock and is now listed on the Nasdaq Global Market under the ticker symbol SZYM.  Solazyme sold 10,975,000 shares of its common stock at a price of $18.00 per share.  Morgan Stanley & Co. Incorporated and Goldman, Sachs & Co. were the lead underwriters.  This is the second company in Keating Capital’s portfolio to complete an IPO in 2011.

Highlights of Keating Capital’s investment in Solazyme:

  • In July 2010, Keating Capital made a $1,000,000 investment in Solazyme’s Series D convertible preferred stock at a price per share of $8.86.
  • Prior to the IPO, Keating Capital’s 112,927 shares of Series D preferred stock converted into 112,927 shares of Solazyme’s common stock, which are subject to a customary six-month lock-up following the IPO.
  • As of March 31, 2011, the most recent date on which Keating Capital valued its investment in Solazyme, these securities were valued at $1,000,000 based on our original purchase price of $8.86 per share.

Founded in 2003 and based in South San Francisco, California, Solazyme is a renewable oil and green bioproducts company and is considered a leader in the development and commercialization of algal oil and bioproducts for the fuels and chemicals, nutrition, and skin and personal care markets.  Solazyme’s unique, proprietary technology allows algae, when fed sugars and plant byproducts, to produce oil and biomaterials in industrial fermentation facilities.  Solazyme’s strategic partners include the U.S. Department of Navy, Chevron, Unilever, Dow Chemical and Roquette.

About Keating Capital, Inc.
Keating Capital (www.KeatingCapital.com) is a business development company that specializes in making pre-IPO investments in innovative, high growth private companies that are committed to and capable of becoming public. Keating Capital provides individual investors with the ability to participate in a unique fund that invests in a private company’s late stage, pre-IPO financing round – an opportunity that has historically been reserved for institutional investors.

To be added to Keating Capital’s distribution list, go to www.KeatingCapital.com/contact.

FOR IMMEDIATE RELEASE
Contact:
Margie L. Blackwell
Investor Relations Director
Keating Capital, Inc.
mb@keatinginvestments.com
(720) 889-0133

Forward-Looking Statements
This press release may contain statements of a forward-looking nature relating to future events. These forward-looking statements are subject to the inherent uncertainties in predicting future results and conditions. These statements reflect Keating Capital’s current beliefs, and a number of important factors could cause actual results to differ materially from those expressed in this press release, including the factors set forth in “Risk Factors” in Keating Capital’s annual report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on February 28, 2011, and subsequent filings with the SEC. Please refer to Keating Capital’s SEC filings for a more detailed discussion of the risks and uncertainties associated with its business, including but not limited to the risks and uncertainties associated with investing in micro- and small-cap companies. Except as required by the federal securities laws, Keating Capital undertakes no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise. The reference to Keating Capital’s Web site has been provided as a convenience, and the information contained on such Web site is not incorporated by reference into this press release.

 

Submitted by Margie L. Blackwell

Tim Keating, CEO of Keating Capital, will be speaking at the Closed-End Fund Symposium for the Retail Investment Community to be held at the New York Stock Exchange on June 1, 2011.  There will be a full day of presentations and discussions on closed-end funds.  Topics will include current market trends and investment strategies and retail investors will have the opportunity to speak with professionals in the closed-end fund industry.

There is no fee to attend and lunch will be served.  Space is limited and registration is required at the CEFNetwork’s Web site.

Pre-IPO Investor’s Portfolio Company Proposes Initial Public Offering

On April 22, 2011, one of Keating Capital, Inc.’s portfolio companies, BrightSource Energy, Inc., filed an S-1 registration statement for a proposed initial public offering of up to $250 million of its common stock. The number of shares and the offering price have not been determined. According to the S-1 filing, Goldman, Sachs & Co., Citigroup Global Markets, Inc. and Deutsche Bank Securities, Inc. are acting as lead underwriters.

Keating Capital made a $2.5 million investment in BrightSource Energy’s $200 million Series E Convertible Preferred Stock financing in February 2011. Other investors in BrightSource include VantagePoint Venture Partners, Draper Fisher Jurvetson, Alstom, CalSTRS, Chevron Technology Ventures and BP Technology Ventures.

Headquartered in Oakland, California, BrightSource is a developer of utility scale solar thermal plants that generate solar energy for utility and industrial companies using its proprietary solar thermal tower technology.

In October 2010, BrightSource announced that it had commenced construction of the 392-megawatt Ivanpah Solar Electric Generating System (“Ivanpah”) in Southern California’s Mojave Desert. According to BrightSource, Ivanpah is the largest solar thermal power plant under construction and will consist of three separate solar thermal power plants, with all three phases expected to be operational by the end of 2013. On April 11, 2011, BrightSource announced that it closed a $1.6 billion loan financing for the Ivanpah project which is guaranteed by the U.S. Department of Energy’s Loan Programs Office. In addition, Google recently announced that it has invested $168 million in the Ivanpah project and NRG Solar, LLC, a subsidiary of NRG Energy, Inc. (NYSE: NRG) intends to invest up to $300 million in Ivanpah.

There are no assurances that the BrightSource IPO will be completed or, if completed, when it may occur. In the event that BrightSource does complete an IPO, any shares received by Keating Capital upon conversion of the Series E Convertible Preferred Stock would be subject to a six-month customary lock-up period.

About Keating Capital, Inc.
Keating Capital, Inc. (www.KeatingCapital.com) is a business development company that specializes in making pre-IPO investments in innovative, high growth private companies that are committed to and capable of becoming public. Keating Capital provides individual investors with the ability to participate in a unique fund that invests in a private company’s late stage, pre-IPO financing round – an opportunity that has historically been reserved for institutional investors.

Contact:
Margie L. Blackwell
Investor Relations Director
Keating Capital, Inc.
mb@keatinginvestments.com
(720) 889-0133

Forward-Looking Statements
This press release may contain statements of a forward-looking nature relating to future events. These forward-looking statements are subject to the inherent uncertainties in predicting future results and conditions. These statements reflect Keating Capital’s current beliefs, and a number of important factors could cause actual results to differ materially from those expressed in this press release, including the factors set forth in “Risk Factors” in Keating Capital’s annual report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on February 28, 2011, and subsequent filings with the SEC. Please refer to Keating Capital’s SEC filings for a more detailed discussion of the risks and uncertainties associated with its business, including but not limited to the risks and uncertainties associated with investing in micro- and small-cap companies. Except as required by the federal securities laws, Keating Capital undertakes no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise. The reference to Keating Capital’s Web site has been provided as a convenience, and the information contained on such Web site is not incorporated by reference into this press release.

Solazyme Proposes $100 Million IPO and Nasdaq Global Market Listing

On March 11, 2011, one of Keating Capital, Inc.’s portfolio companies, Solazyme, Inc., filed an S-1 registration statement to go public through a $100 million initial public offering of its common stock. Solazyme intends to list its shares on the Nasdaq Global Market under the symbol “SZYM.” Morgan Stanley and Goldman, Sachs & Co. are acting as lead underwriters.

Keating Capital made a $1 million investment in Solazyme in July 2010.

Solazyme is based in San Francisco, California, and is a leader in the development and commercialization of algal oil and bioproducts for the fuels and chemicals, nutrition, and skin and personal care markets.

About Keating Capital, Inc.

Keating Capital, Inc. (www.KeatingCapital.com) is a business development company that specializes in making pre-IPO investments in innovative, high growth private companies that are committed to and capable of becoming public. Keating Capital provides individual investors with the ability to participate in a unique fund that invests in a private company’s late stage, pre-IPO financing round – an opportunity that has historically been reserved for institutional investors.

FOR IMMEDIATE RELEASE
Contact:
Margie L. Blackwell
Investor Relations Director
Keating Capital, Inc.
mb@keatinginvestments.com
(720) 889-0133

Forward-Looking Statements
This press release may contain statements of a forward-looking nature relating to future events. These forward-looking statements are subject to the inherent uncertainties in predicting future results and conditions. These statements reflect Keating Capital’s current beliefs, and a number of important factors could cause actual results to differ materially from those expressed in this press release, including the factors set forth in “Risk Factors” in Keating Capital’s annual report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on February 28, 2011, and subsequent filings with the SEC. Please refer to Keating Capital’s SEC filings for a more detailed discussion of the risks and uncertainties associated with its business, including but not limited to the risks and uncertainties associated with investing in micro- and small-cap companies. Except as required by the federal securities laws, Keating Capital undertakes no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise. The reference to Keating Capital’s Web site has been provided as a convenience, and the information contained on such Web site is not incorporated by reference into this press release.

Venture-Backed Organic Waste Manager Receives Equity Investment from Pre-IPO Fund


Keating Capital, Inc. announced that it made a $2.5 million investment in the Series B Convertible Preferred Stock offering of Harvest Power, Inc. (www.HarvestPower.com) on March 9, 2011. This investment was part of a $51.7 million Series B financing led by Generation Investment Management, LLP. Other investors in the Series B round include Kleiner PerkinsWaste Management (NYSE: WM), DAG VenturesMunich Venture Partners and TriplePoint Capital.

Founded in 2008 and based in Waltham, Massachusetts, Harvest Power acquires, owns and operates organic waste facilities that convert organic waste, such as food scraps and yard debris, into compost, mulch and renewable energy. Harvest Power’s recycling operations reduce the amount of organic waste that needs to be landfilled or incinerated. Its existing operating facilities are located in California, Pennsylvania, and British Columbia, Canada. Harvest Power enters into multi-year contracts with municipalities and waste haulers who pay a tipping fee to Harvest Power to accept organic waste at its facilities.

Harvest Power recently announced that it has broken ground on its first renewable energy project, a commercial-scale high solids anaerobic digestion facility, to be built at its Vancouver, British Columbia composting plant. When completed, the facility is expected to produce organic waste-derived electricity that can be sold to the local utility, BC Hydro. The facility is projected to be operational by the end of 2011.

Harvest Power has been recognized with a number of awards including the Global Cleantech 100 by The Guardian/Cleantech Group and the Going Green Top 50.

About Keating Capital, Inc.

Keating Capital (www.KeatingCapital.com) is a business development company that specializes in making pre-IPO investments in innovative, high growth private companies that are committed to and capable of becoming public. Keating Capital provides individual investors with the ability to participate in a unique fund that invests in a private company’s late stage, pre-IPO financing round - an opportunity that has historically been reserved for institutional investors.

Forward-Looking Statements
This press release may contain statements of a forward-looking nature relating to future events. These forward-looking statements are subject to the inherent uncertainties in predicting future results and conditions. These statements reflect Keating Capital’s current beliefs, and a number of important factors could cause actual results to differ materially from those expressed in this press release, including the factors set forth in “Risk Factors” in Keating Capital’s annual report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on February 28, 2011, and subsequent filings with the SEC. Please refer to Keating Capital’s SEC filings for a more detailed discussion of the risks and uncertainties associated with its business, including but not limited to the risks and uncertainties associated with investing in micro- and small-cap companies. Except as required by the federal securities laws, Keating Capital undertakes no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise. The reference to Keating Capital’s Web site has been provided as a convenience, and the information contained on such Web site is not incorporated by reference into this press release.

Contact:
Margie L. Blackwell
Investor Relations Director
Keating Capital, Inc.
mb@keatinginvestments.com
(720) 889-0133